02:46:53 EDT Fri 17 May 2024
Enter Symbol
or Name
USA
CA



Cipher Pharmaceuticals Inc
Symbol CPH
Shares Issued 25,077,523
Close 2023-05-04 C$ 3.28
Market Cap C$ 82,254,275
Recent Sedar Documents

Cipher Pharmaceuticals to release Q1 results May 11

2023-05-04 17:54 ET - News Release

Mr. James Bowen reports

CIPHER PHARMACEUTICALS SCHEDULES Q1 2023 EARNINGS RELEASE AND CONFERENCE CALL

Cipher Pharmaceuticals Inc. will release its financial results for the first quarter of 2023 on Thursday, May 11, 2023. The company will also host a conference call on Friday, May 12, 2023, at 8:30 a.m. ET to discuss the results and corporate developments.

Conference call details

Date:  Friday, May 12, 2023

Time:  8:30 a.m. ET

Dial-in number:  416-764-8650 or 888-664-6383

Conference ID:  40452017

Replay dial-in:  888-390-0541 (playback 452017 followed by the pound key)

Expires:  May 19, 2022

About Cipher Pharmaceuticals Inc.

Cipher Pharmaceuticals is a specialty pharmaceutical company with a robust and diversified portfolio of commercial and early- to late-stage products. Cipher acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and currently markets those products either directly in Canada or indirectly through partners in Canada, the United States and South America.

© 2024 Canjex Publishing Ltd. All rights reserved.